PMC:7405836 / 79015-79135 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T271","span":{"begin":63,"end":71},"obj":"Body_part"}],"attributes":[{"id":"A271","pred":"fma_id","subj":"T271","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Several laboratories around the world are currently developing antibody-based diagnostic tests against SARS-CoV-2 (157)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T744","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"T745","span":{"begin":103,"end":107},"obj":"Disease"}],"attributes":[{"id":"A744","pred":"mondo_id","subj":"T744","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A745","pred":"mondo_id","subj":"T745","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Several laboratories around the world are currently developing antibody-based diagnostic tests against SARS-CoV-2 (157)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T745","span":{"begin":89,"end":94},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Several laboratories around the world are currently developing antibody-based diagnostic tests against SARS-CoV-2 (157)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T560","span":{"begin":0,"end":120},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Several laboratories around the world are currently developing antibody-based diagnostic tests against SARS-CoV-2 (157)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2263","span":{"begin":103,"end":113},"obj":"Species"}],"attributes":[{"id":"A2263","pred":"tao:has_database_id","subj":"2263","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Several laboratories around the world are currently developing antibody-based diagnostic tests against SARS-CoV-2 (157)."}